Skip to main content
Advicenne logo

Advicenne — Investor Relations & Filings

Ticker · ALDVI ISIN · FR0013296746 LEI · 969500YT5VMEYAYODW34 PA Manufacturing
Open in API
Filings indexed 259 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country FR France
Listing PA ALDVI

About Advicenne

https://advicenne.com

Advicenne is a specialty pharmaceutical company dedicated to developing and commercializing treatments for rare renal diseases. The company focuses on addressing unmet medical needs in nephrology for both children and adults. Its lead product, Sibnayal®, is an approved treatment for distal Renal Tubular Acidosis (dRTA). Advicenne is committed to improving the lives of patients with rare kidney conditions by developing therapeutics, including pediatric-friendly formulations, suitable for patients of all ages.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings
2026-05-05 English
Informations privilégiées / Autres communiqués
Regulatory Filings
2026-05-05 French
Terms of availability of a registration document or its updates
Report Publication Announcement Classification · 90% confidence The document is a press release announcing that Advicenne’s 2025 Universal Registration Document (including the annual report, management report, corporate governance report, and statutory auditors’ reports) has been filed with the AMF and is available on the company and regulator websites. It does not contain the report itself but informs investors of its publication. Under our taxonomy, this is a Report Publication Announcement (RPA).
2026-04-24 English
Modalités de mise à disposition de document de référence ou de ses actualisations
Report Publication Announcement Classification · 95% confidence The document is a press release announcing that Advicenne has filed its "Document d'Enregistrement Universel 2025" with the AMF and made it available on its website. It does not contain the full report itself but rather notifies investors of its publication. This aligns with the Report Publication Announcement category rather than the report itself.
2026-04-24 French
Inside Information / News release on accounts, results
Earnings Release Classification · 95% confidence The document is a press release issued on March 26, 2026, announcing Advicenne’s full-year 2025 financial results, including key highlights, summary tables, CEO commentary, and outlook. It is not the complete Universal Registration Document (the full annual report) but rather the initial announcement of annual financial results. This aligns with the definition of an Earnings Release (Code: ER). FY 2025
2026-03-26 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 98% confidence The document is a press release announcing Advicenne’s full-year 2025 financial results with top‐line bullet points, summary tables, management commentary, and outlook. It is not the comprehensive statutory annual report itself but the initial earnings announcement. This fits the Earnings Release category. FY 2025
2026-03-26 French

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.